Anxiety and Depressive symptoms. Anxiety disorder, unspecified
Conditions
Interventions
Intervention 1: Experimental group was participated in transdiagnostic group therapy at 8 weeks for 2 hours. Therapeutic components of transdiagnostic group therapy were including: emotional awareness
Prevention
Experimental group was participated in transdiagnostic group therapy at 8 weeks for 2 hours. Therapeutic components of transdiagnostic group therapy were including: emotional awareness training, cogni
Cognitive group therapy as an treatment as usual was used for control group at 8sessons. Basic techniques of cognitive therapy such as cognitive restructuring and down ward arrow were used in control
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: anxiety and depression symptoms based on the cut-off of 18 and higher in the depression subscale and score of 16 and higher in the anxiety subscale of The Depression, Anxiety, and Stress Scale (DASS-42; Lovibond & Lovibond, 1993). Exclusion criteria: Having axes I or II disorders; receiving psychotherapy or medication; having serious physical problems
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depressive symptoms. Timepoint: pre, post and after 3 maonth follow up. Method of measurement: self report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety symptoms. Timepoint: pre, post and after 3 month follow-up. Method of measurement: self report questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbolfazl Mohammadi
Tehran University of Medical Sciences
Outcome results
None listed